Disc Medicine Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:IRON Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
17 Jun 24	BuyUS$3,000,024	OrbiMed Advisors LLC	Company	83,334	US$36.00
17 Jun 24	BuyUS$8,000,028	Atlas Venture L.P.	Company	222,223	US$36.00
05 Mar 24	SellUS$1,922,540	Atlas Venture L.P.	Company	26,157	US$73.50
23 Jan 24	SellUS$10,147,500	Atlas Venture L.P.	Company	150,000	US$67.65
10 Jan 24	SellUS$3,200,000	Atlas Venture L.P.	Company	50,000	US$64.00
14 Dec 23	SellUS$7,902,266	OrbiMed Advisors LLC	Company	134,200	US$60.16
14 Dec 23	SellUS$11,684,586	Atlas Venture L.P.	Company	190,163	US$65.77
14 Dec 23	SellUS$24,584,100	OrbiMed Advisors LLC	Company	433,200	US$56.75
16 Sep 23	SellUS$18,991,727	Atlas Venture L.P.	Company	357,449	US$53.22
15 Aug 23	SellUS$18,845,200	Atlas Venture L.P.	Company	359,000	US$54.80
28 Jun 23	SellUS$57,625,000	Novo Holdings A/S	Company	1,250,000	US$46.10

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32.5%.

Top 25 shareholders own 94.01% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12%	Access Industries, Inc.	3,558,426	US$160.1m	0%	no data
12%	Access Industries Holdings Llc	3,558,426	US$160.1m	13.3%	no data
8.6%	Atlas Venture L.P.	2,551,238	US$114.8m	11.5%	11.97%
8.06%	Paradigm Biocapital Advisors LP	2,389,902	US$107.5m	0.17%	4.28%
7.3%	FMR LLC	2,166,819	US$97.5m	437%	0.01%
6.02%	OrbiMed Advisors LLC	1,785,571	US$80.3m	4.9%	1.15%
4.49%	Bain Capital Life Sciences Investors, LLC	1,332,545	US$59.9m	1.16%	6.23%
3.68%	State Street Global Advisors, Inc.	1,091,211	US$49.1m	95.1%	no data
3.18%	T. Rowe Price Group, Inc.	944,213	US$42.5m	59.8%	no data
3.17%	Perceptive Advisors LLC	939,866	US$42.3m	-8.13%	0.89%
3.04%	BlackRock, Inc.	901,595	US$40.6m	3.82%	no data
2.65%	Frazier Life Sciences Management, LP	785,000	US$35.3m	0%	1.7%
2.64%	The Vanguard Group, Inc.	782,751	US$35.2m	2.38%	no data
2.26%	Wellington Management Group LLP	670,482	US$30.2m	277%	no data
2.24%	Deerfield Management Company, L.P. Series C	665,535	US$29.9m	43.3%	0.56%
1.94%	Adage Capital Management, L.P.	574,464	US$25.8m	-23.4%	0.05%
1.76%	Janus Henderson Group plc	521,773	US$23.5m	17.7%	0.01%
1.67%	AllianceBernstein L.P.	496,881	US$22.3m	36.9%	0.01%
1.63%	LSV Capital Management, LLC	483,609	US$21.8m	0%	52.48%
1.23%	Rock Springs Capital Management LP	363,468	US$16.3m	0%	0.44%
1.1%	Citadel Advisors LLC	325,724	US$14.7m	73.3%	0.02%
0.86%	Saturn V Capital Management LP	254,803	US$11.5m	293%	4.72%
0.85%	First Turn Management, LLC	252,673	US$11.4m	60.7%	1.94%
0.83%	Geode Capital Management, LLC	245,774	US$11.1m	7.13%	no data
0.83%	Polar Capital Holdings Plc	244,928	US$11.0m	-55.2%	0.04%